Home | Market Signals | Green Stocks with Most Upside to Analyst Target Price | New Green AI Signals | Breaking Out | Big Tech Stocks | Solar Stocks | Chip Stocks | Airline Stocks | Social Media Stocks | Oil Stocks| Discount Store Stocks | Entertainment Stocks | EV Stocks | Restaurant Stocks | Heavy Equipment Stocks | Aerospace Stocks | Home Builders | Bank Stock Signals | Cruise Ship Stock Signals

How to Read and Trade AI Powered Stock Charts
Enter Stock Symbol to View AI powered Stock Chart


All Chart Prices as of Previous Day Close

Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.

Last Price: 6.73 - Change: 0.35 - Change %: 5.4859
12/07/2023 16:05:00 EST

Iovance Biotherapeutics Inc (IOVA)

Industry: Biotechnology

Price Support Resistance

In the past 30 trading days, IOVA has been trading in a range between $5.79 and $3.30 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.

IOVA is trading between resistance at $7.50 about 11% to the upside and support at $6.27 -7% to the downside. If it can break above the resistance, it could have some more upside to the next line of resistance at $9.06, about a 35% move. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.

Upside / Downside Potential

Iovance Biotherapeutics Inc (IOVA) entered a Green zone 17 days ago on the AI powered stock chart. Wall Street analysts have a recent rating of 4.500, which is a Strong Buy. The current analyst target price is $22.36, which gives it a potential upside of 232.24 % from the recent price of 6.73. The stock is trading 39.08% (potential upside) below its 52 week high of $9.36 and 109.66 % (potential downside) above its 52 week low of $3.21 - based on the recent price.

Company Summary

Iovance Biotherapeutics, Inc, a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company's lead product candidate is lifileucel that is in Phase II clinical trial for the treatment of metastatic melanoma and cervical cancer.

IOVA Website


Why Is Iovance Biotherapeutics (IOVA) Up 53% Since Last Earnings Report?
Iovance Biotherapeutics (IOVA) reported earnings 30 days ago. What's next for the stock?
Source: Zacks Investment Research
Thu, 07 Dec 2023 12:48:04 -0500
Sentiment: Positive
3 Penny Stocks to Buy to Turn $1 into $100: November 2023
In this market cycle that we are experiencing, new opportunities arise to take advantage of over the next few years. There is no better way to take advantage of these opportunities than through penny stocks.
Source: InvestorPlace
Wed, 22 Nov 2023 14:22:43 -0500
Sentiment: Neutral
Why Iovance Biotherapeutics Stock Is Jumping Today
Goldman Sachs initiated a buy recommendation on Iovance with a $12 price target. Many on Wall Street like the stock because of the potential near-term approval of its promising melanoma drug.
Source: The Motley Fool
Mon, 20 Nov 2023 12:00:21 -0500
Sentiment: Positive
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SAN CARLOS, Calif., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that on November 16, 2023 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 59,950 shares of Iovance's common stock to nine new non-executive employees.
Source: GlobeNewsWire
Fri, 17 Nov 2023 17:00:00 -0500
Sentiment: Neutral
Why Iovance Biotherapeutics Stock Is Marching Higher Today
Biotech stocks are slumping yet again today. However, Iovance Biotherapeutics is swimming against the current thanks to excitement over its adoptive cell therapy.
Source: The Motley Fool
Wed, 08 Nov 2023 13:03:43 -0500
Sentiment: Positive
Instituions Institution %: 91.405
Last QTR Institution change: 24947076

Insiders %: 0.327
Insiders Purchases last QTR: 5020000
Insiders Sales last QTR: 0
Insiders Net last QTR: 5020000

Analyst Ratings
Target Price: 22.36
Overall Rating: 4.5
Strong Buys (5): 8
Buys (4): 5
Holds (3): 1
Sells (2): 0
Strong Sells (1): 0

52 Week Hi: 9.36
52 Week Low: 3.21
Beta: 0.36
50 Day MA: 4.4546
200 Day MA: 6.2499

Earnings / Revenue Trends
Qtr Earnings Growth YOY: 0
Qtr Revenue Growth YOY: 0
Forward PE: 0
Trailing PE: 0

Benefits of StockChartsAI.com System:

  • Get a Daily List of Stocks Starting New Trends
  • Upload Your Stocks to Quickly See and Track Signals
  • Easy to Understand AI Stock Signals
  • Analysis of Historical Signal Trend Analysis for each stock
  • Search/View AI Stock Signals of Russel 1000 Stocks
  • Easy to Understand AI Stock Signals
  • And MUCH MUCH more!


Stock Analyzed Each Night


Easily Upload Track Your Stocks


See Lists of Stocks Starting New Trends

The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.